Corrigendum to “Oligoclonal myelin-reactive T-cell infiltrates derived from neuromyelitis optica spectrum disorder (NMOSD) lesions are enriched in Th17 cells” [Clinical Immunology 130 (2009) 133–144] (Clinical Immunology (2009) 130(2) (133–144), (S152166160800819X), (10.1016/j.clim.2008.08.030));Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells

Clinical Immunology

Volumn 130, Issue 2, 2009, Pages 133-144

  Montes, Monica ^a   Zhang, Xin ^a   Berthelot, Laureline ^b   Laplaud, David Axel ^b   Brouard, Sophie ^b   Jin, Jianping ^c   Rogan, Sarah ^a   Armao, Diane ^a   Jewells, Valerie ^a   Soulillou, Jean Paul ^b   Markovic Plese, Silva ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b INSERM   (France)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Autoimmunity; Demyelinating CNS inflammatory lesions; Human; T cells

Indexed keywords

CYTOKINE; MYELIN BASIC PROTEIN; RETINOIC ACID; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADOLESCENT; ARTICLE; AUTOPSY; CASE REPORT; CELL INFILTRATION; CELL PROLIFERATION; COMPLEMENTARITY DETERMINING REGION; FEMALE; GENE EXPRESSION; GENOMICS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RECEPTOR UPREGULATION; RECURRENT DISEASE; REMISSION; T LYMPHOCYTE; TH17 CELL; UNINDEXED SEQUENCE; WHITE MATTER;

EID: 58049087366     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2022.108967     Document Type: Erratum

References (32)

1. Sospedra M., and Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23 (2005) 683-747
2. Bielekova B., Goodwin B., Richert N., Cortese I., Kondo T., Afshar G., Gran B., Eaton J., Antel J., Frank J.A., McFarland H.F., and Martin R. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat. Med. 6 (2000) 1167-1175
3. Markovic-Plese S., and McFarland H.F. Immunopathogenesis of the multiple sclerosis lesion. Curr. Neurol. Neurosci. Rep. 1 (2001) 257-262
4. Arenz M., Herzog-Hauff S., Meyer zum Buschenfelde K.H., and Lohr H.F. Antigen-independent in vitro expansion of T cells does not affect the T cell receptor V beta repertoire. J. Mol. Med. 75 (1997) 678-686
5. Muraro P.A., Wandinger K.P., Bielekova B., Gran B., Marques A., Utz U., McFarland H.F., Jacobson S., and Martin R. Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders. Brain 126 (2003) 20-31
6. Laplaud D.A., Ruiz C., Wiertlewski S., Brouard S., Berthelot L., Guillet M., Melchior B., Degauque N., Edan G., Brachet P., Damier P., and Soulillou J.P. Blood T-cell receptor beta chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution. Brain 127 (2004) 981-995
7. Skulina C., Schmidt S., Dornmair K., Babbe H., Roers A., Rajewsky K., Wekerle H., Hohlfeld R., and Goebels N. Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 2428-2433
8. Wingerchuk D.M., Hogancamp W.F., O'Brien P.C., and Weinshenker B.G. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53 (1999) 1107-1114
9. Wingerchuk D.M., Lennon V.A., Pittock S.J., Lucchinetti C.F., and Weinshenker B.G. Revised diagnostic criteria for neuromyelitis optica. Neurology 66 (2006) 1485-1489
10. Cree B.A., Khan O., Burdette D., Goodin D.S., Cohen J.A., Marrie R.A., Glidden D., Weinstock-Guttman B., Reich D., Patterson N., Haines J.L., Pericak-Vance M., DeLoa C., Oksenberg J.R., and Hauser S.L. Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology 63 (2004) 2039-2045
11. Muraro P.A., Cassiani-Ingoni R., Chung K., Packer A.N., Sospedra M., and Martin R. Clonotypic analysis of cerebrospinal fluid T cells during disease exacerbation and remission in a patient with multiple sclerosis. J. Neuroimmunol. 171 (2006) 177-183
12. Comabella M., and Martin R. Genomics in multiple sclerosis-current state and future directions. J. Neuroimmunol. 187 (2007) 1-8
13. Babbe H., Roers A., Waisman A., Lassmann H., Goebels N., Hohlfeld R., Friese M., Schroder R., Deckert M., Schmidt S., Ravid R., and Rajewsky K. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192 (2000) 393-404
14. Junker A., Ivanidze J., Malotka J., Eiglmeier I., Lassmann H., Wekerle H., Meinl E., Hohlfeld R., and Dornmair K. Multiple sclerosis: T-cell receptor expression in distinct brain regions. Brain 130 (2007) 2789-2799
15. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., and Bo L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338 (1998) 278-285
16. Barnett M.H., and Prineas J.W. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 55 (2004) 458-468
17. Markovic-Plese S., Fukaura H., Zhang J., al-Sabbagh A., Southwood S., Sette A., Kuchroo V.K., and Hafler D.A. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J. Immunol. 155 (1995) 982-992
18. Zhang J., Markovic-Plese S., Lacet B., Raus J., Weiner H.L., and Hafler D.A. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179 (1994) 973-984
19. Ponomarev E.D., and Dittel B.N. Gamma delta T cells regulate the extent and duration of inflammation in the central nervous system by a Fas ligand-dependent mechanism. J. Immunol. 174 (2005) 4678-4687
20. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., and Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126 (2006) 1121-1133
21. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., Basham B., Smith K., Chen T., Morel F., Lecron J.C., Kastelein R.A., Cua D.J., McClanahan T.K., Bowman E.P., and de Waal Malefyt R. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8 (2007) 950-957
22. Ziolkowska M., Koc A., Luszczykiewicz G., Ksiezopolska-Pietrzak K., Klimczak E., Chwalinska-Sadowska H., and Maslinski W. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J. Immunol. 164 (2000) 2832-2838
23. Cho M.L., Ju J.H., Kim K.W., Moon Y.M., Lee S.Y., Min S.Y., Cho Y.G., Kim H.S., Park K.S., Yoon C.H., Lee S.H., Park S.H., and Kim H.Y. Cyclosporine A inhibits IL-15-induced IL-17 production in CD4+ T cells via down-regulation of PI3K/Akt and NF-kappaB. Immunol. Lett. 108 (2007) 88-96
24. Pashenkov M., Mustafa M., Kivisakk P., and Link H. Levels of interleukin-15-expressing blood mononuclear cells are elevated in multiple sclerosis. Scand. J. Immunol. 50 (1999) 302-308
25. Chen Z., Laurence A., Kanno Y., Pacher-Zavisin M., Zhu B.M., Tato C., Yoshimura A., Hennighausen L., and O'Shea J.J. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 8137-8142
26. Chen Z., and O'Shea J.J. Regulation of IL-17 production in human lymphocytes. Cytokine. 41 (2008) 71-78
27. Hafler D.A., Compston A., Sawcer S., Lander E.S., Daly M.J., De Jager P.L., de Bakker P.I., Gabriel S.B., Mirel D.B., Ivinson A.J., Pericak-Vance M.A., Gregory S.G., Rioux J.D., McCauley J.L., Haines J.L., Barcellos L.F., Cree B., Oksenberg J.R., and Hauser S.L. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357 (2007) 851-862
28. Bruck W., Porada P., Poser S., Rieckmann P., Hanefeld F., Kretzschmar H.A., and Lassmann H. Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann. Neurol. 38 (1995) 788-796
29. Peng X., Jin J., Giri S., Montes M., Sujkowski D., Tang Y., Smrtka J., Vollmer T., Singh I., and Markovic-Plese S. Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis. J. Neuroimmunol. 178 (2006) 130-139
30. Pannetier C., Even J., and Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol. Today 16 (1995) 176-181
31. Gorochov G., Neumann A.U., Kereveur A., Parizot C., Li T., Katlama C., Karmochkine M., Raguin G., Autran B., and Debre P. Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nat. Med. 4 (1998) 215-221
32. Sebille F., Gagne K., Guillet M., Degauque N., Pallier A., Brouard S., Vanhove B., Delsuc M.A., and Soulillou J.P. Direct recognition of foreign MHC determinants by naive T cells mobilizes specific Vbeta families without skewing of the complementarity-determining region 3 length distribution. J. Immunol. 167 (2001) 3082-3088